Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
John Hancock Pfd Income Fund II | HPF | Nov 25, 2024 | 17.22 | +0.23 |
John Hancock Preferred Income Fund | HPI | Nov 25, 2024 | 17.41 | +0.23 |
John Hancock Preferred Income Fund III | HPS | Nov 25, 2024 | 15.54 | +0.58 |
John Hancock Premium Dividend Fund | PDT | Nov 25, 2024 | 13.06 | +0.15 |
John Hancock Tax Advantaged Dividend Fund | HTD | Nov 25, 2024 | 23.42 | -0.34 |
John Marshall Bancorp | JMSB | Nov 25, 2024 | 23.86 | +1.02 |
John Wiley & Sons A | WLY | Nov 25, 2024 | 53.13 | +1.86 |
John Wiley & Sons B | WLYB | Nov 25, 2024 | 52.90 | +0.61 |
Johnson & Johnson | JNJ | Nov 25, 2024 | 155.78 | +0.39 |
Johnson Controls International | JCI | Nov 25, 2024 | 83.34 | -0.13 |
Johnson Outdoors A | JOUT | Nov 25, 2024 | 34.27 | +2.70 |
Joint Stock Company Kaspi.kz | KSPI | Nov 25, 2024 | 106.19 | +2.11 |
Jones Lang LaSalle | JLL | Nov 25, 2024 | 283.67 | +7.75 |
Journey Medical | DERM | Nov 25, 2024 | 5.74 | +6.89 |
Jowell Global | JWEL | Nov 25, 2024 | 3.42 | +1.18 |
JOYY ADR | YY | Nov 25, 2024 | 34.75 | +2.48 |
JP Morgan Chase | JPM | Nov 25, 2024 | 250.29 | +0.70 |
JP Morgan Chase & Co EE Pref | JPM-C | Nov 25, 2024 | 25.49 | +0.43 |
JP Morgan Chase & Co GG Pref | JPM-J | Nov 25, 2024 | 22.38 | +0.58 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Nov 25, 2024 | 25.29 | +0.48 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Nov 25, 2024 | 56.69 | +0.21 |
Jumia Technologies ADR | JMIA | Nov 25, 2024 | 4.11 | +8.16 |
Junee Limited - Ordinary Shares | JUNE | Nov 25, 2024 | 4.76 | -4.80 |
Junior Gold Miners ETF Market Vectors | GDXJ | Nov 25, 2024 | 46.82 | -3.14 |
Juniper Networks | JNPR | Nov 25, 2024 | 36.20 | +0.81 |
JVSPAC Acquisition | JVSAU | Nov 25, 2024 | 10.90 | 0.00 |
JVSPAC Acquisition | JVSA | Nov 25, 2024 | 10.39 | +0.10 |
JX Luxventure | JXJT | Nov 25, 2024 | 1.22 | +1.67 |
Kadant | KAI | Nov 25, 2024 | 418.68 | -0.08 |
Kairos Pharma | KAPA | Nov 25, 2024 | 1.70 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.